drug
Hetlioz LQ
Marketedupdated 5mo agoby $VNDA Vanda Pharmaceuticals Inc.
Approvedcommunity read0 votes
all catalysts(0)
nothing on the calendar yet
Trials studying Hetlioz LQ
- phase3Evaluating the Effects of Tasimelteon vs. Placebo in Delayed Sleep-Wake Phase Disorder (DSWPD)
- EP1The Effects of Tasimelteon in Participants With REM Behavior Disorder (RBD)
- phase3Evaluating the Effects of Tasimelteon vs. Placebo in Treating Pediatric Insomnia
- phase3Evaluating the Effects of Tasimelteon Vs. Placebo in Delayed Sleep-Wake Phase Disorder (DSWPD) and the CRY1Δ11 Variant
- phase3Safety Study of Tasimelteon for Treatment of Non-24-Hour-Sleep-Wake Disorder in Blind Individuals With No Light Perception
- phase1Study of the Pharmacokinetics and Safety of Tasimelteon in Children and Adolescents
- phase1Evaluation of Next-Day Residual Effects of Tasimelteon Compared With Placebo and Active Control in Healthy Subjects
- phase3Evaluating the Effects of Tasimelteon in Individuals With Autism Spectrum Disorder (ASD) and Sleep Disturbances
News(0)
no news has mentioned this drug yet
Data sources
last refreshed 39m ago
Found something off?
comments(0)
5-min edit window · permanent after that